Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT Imaging in Patients With Prostate Cancer on Active Surveillance
NCT07285057Phase 2Recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Feb 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flotufolastat f 18 in prostate cancer (PCa), sponsored by Icahn School of Medicine at Mount Sinai. Started Feb 2026; status: recruiting.
02
Drugs
flotufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07285057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07285057.